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Abstract
The aim of this study was to assess the profile of mucins (MUC1, MUC2, MUC5AC) in the intestinal metaplasia (IM) of 
the gastric mucosa through the immunohistochemical method. Methods: To identify the metaplastic areas in the gastric mucosa, 
chromoendoscopy was employed using 0.5% solution of methylene blue. The expression of the profile of the mucins was determined 
using immunohistochemistry with MUC1, MUC5AC, and MUC2 antibodies (clone Ma695, clone CLH2, Ccp58 and CLH5, «Novocastra 
«Great Britain). Results: In the regions adjacent to the adenocarcinoma and neoplastic modified cells, a visible weak expression of 
MUC2 and MUC5AC was observed. In the case of complete IM, a visibly maximum MUC2 expression was observed in the goblet 
cells; thus, the MUC5AC, MUC1, and MUC6 marking were absent in the columnar epitheliocytes with the brush border. In the case 
of incomplete IM, along with the positive MUC2 markings of the goblet cells, the presence of gastric mucin (MUC5AC) has been 
observed in 25% of such patients with chronic atrophic gastritis (CAG) having incomplete IM; however, in the columnar epitheliocytes 
the characteristic occurrence of gastric mucin (MUC5AC) was observed in 100% of the patients while a small amount of MUC2 was 
recorded in 15% of patients. Conclusion:  The MUC5AC expression of the gastric mucins in the columnar epithelial cells and the goblet 
exocrinocytes marks the formation of the gastrointestinal phenotype viz., incomplete intestinal metaplasia, along with the simultaneous 
production of the MUC2 by the goblet cells. The decrease with further loss of the protective MUC5AC production by the columnar 
epithelial cells and goblet exocrinocytes that were found in the regions of severe dysplasia and IM, adjacent to the neoplastic altered 
cells, may serve as additional criteria of early malignancy of the gastric mucosa.
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Introduction
The current understanding of the gastrointestinal barrier 
links the ability of the surface and the glandular epithelial cells 
to synthesize mucin [1,2]. At the same time, the epithelial mucins 
produced by the epithelial cells are a large group of glycosylated 
proteins  secreted  and  embedded  in  the  plasmolemmal 
glycoproteins. In the epithelial tissues, 13 types of mucin are 
found, forming two classes of compounds: the transmembrane 
and  secretory  mucins.  MUC1  is  one  of  the  transmembrane 
mucins of the digestive tract cells. It is distributed on the cell 
surface and acts as a signaling molecule. The MUC3 and MUC4 
present within the same cells are regarded as the original form of 
the secretory mucins. The gel-forming mucins of the digestive 
tract, however, include MUC2, MUC5AC, MUC4B, and MUC6. 
They are actively expressed by the epithelial cells and represent 
a  variable  number  of  peptides  rich  in  serine,  threonine  and 
proline, coupled with a large number of oligosaccharide chains. 
According  to  the  information available [3],  the  expression  of 
the  membrane  glycoproteins  increases  nearly  tenfold  in  the 
transformed cells, with shortening of the carbohydrate chains. 
Such  changes  triggered  by  the  mucin-producing  cells  are 
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considered to be a carcinogenic marker. Mechanisms that are 
responsible for the orientation of the protein molecules in the 
bilayer of the cytomembranes, stabilization of the spatial structure 
of  the  proteins,  transmembrane  and  intracellular  transport  of 
substances (including the transfer of the hydrolytic enzymes from 
the Golgi complex to lysosomes), and the molecular mechanisms 
of  intercellular  recognition  are  associated  with  the  specific 
structure of the carbohydrate determinants of the glycoproteins. 
As is evident, these mechanisms play an important role in the 
maturation and differentiation of cells, histogenesis and organ 
morphogenesis, with the contact inhibition of cell proliferation, 
providing immune surveillance. This forms the basis of the most 
important manifestations of malignant growth [4-7].
Today, it has been proved that CAG is one of the main 
elements responsible for the carcinogenesis. According to the 
recommendations  of  the  International  Atrophy  Group  (2002) 
two main types of atrophy are distinguishable, metaplastic and 
non-metaplasic  [8].  Non-metaplasic  atrophy  is  characterized 
by the loss of glands, accompanied by fibrosis or fibromuscular 
proliferation in the lamina propria of the gastric mucosa; however, 
metaplastic atrophy is characterized by the replacement of the 
gastric glands by metaplastic ones (including enteric), which can 
happen in the setting of other signs of atrophy. Any disturbance in 
the synthesis or secretion released by the glandular cells triggers 
a change in the chemical composition, under the influence of the 
exogenous and endogenous factors in the CAG with IM; however, 
this process has not yet been studied thoroughly enough. Such 
transformations are some of the most important components of 
the mucosal barrier and may bear great significance in relation to 
the morphogenetic and clinical differences of the CAG with  IM 
in different patient groups.
Material and Methods 
Over a period of six years, 98 patients were examined. 
They had been sent to the endoscopy departments of Vinnytsya 
hospitals to clarify the clinical diagnosis. Of these patients, 52 
(53%) were male and 46 (47%) were female. From among these 
98 patients, we selected 68 with the CAG with IM who constituted 
the main group for further investigation because IM was closely 
associated with this disease. The comparison group included 30 
individuals with the CAG, but without IM. The average age of 
the patients examined in the dynamics was 52.96 ± 1.13, and 
the average duration of the disease at the time of IM diagnosis 
was 2.6 ± 0.63 years. Multiple biopsies were performed during 
the  endoscopy  and  chromoendoscopy  with  0.5%  solution  of 
methylene blue (two biopsies from the body and antrum, and one 
from an area in the angle of the stomach) taking into account the 
requirements of the modified Sydney system of chronic gastritis 
diagnosis. The areas of the gastric mucosa were stained for the 
following histological study of the biopsies. The biopsy material 
was fixed in 10% neutral formalin and after routine processing 
some paraffin blocks were produced. Sectioning was done to 5.7 
micron thickness. To define the metaplastic changes of the gastric 
mucosa, routine histological (staining with H&E and Van Gieson) 
and histochemical (combined high iron diamine and alcian blue 
technique, orsein combined with alcian blue, Gomory aldehyde 
fuchsin, alcian blue with pH 1.0 and 2.5 together with the PAS 
reaction) methods were employed. To identify the presence of 
Helicobacter pylori (H. pylori), a rapid urease test was conducted, 
the cytology was tested with a Pappenheim stain, and from the 
histological  viewpoint  staining  was  done  using  Romanovsky-
Giemsa and toluidine blue stain. 
Immunohistochemical studies  were  performed  on 
paraffin sections using the streptavidin-biotin method (“DAKO”, 
Denmark, LSAB2 Systems, HRP). The expression of the mucin 
profile was  determined using  the antibodies of  MUC1,  MUC 
5AC, MUC2, and MUC6 (clone Ma695, clone CLH2, Ccp58, 
and  CLH5,  “Novocastra  “Great  Britain).  In  preparations  at 
400-fold magnification the rate of intestinal differentiation was 
determined (nuclear label CDX2) in 5 randomly selected fields of 
view (≥ 500 cells) as a percentage of the positively stained nuclei 
of the epithelial cells of the gastric mucosa in three compartments 
(I - surface and foveolar epithelium; II - neck region, III - base 
of the glands, middle and lower third of the glands to the basal 
sections). To evaluate the expression of the mucins (MUC5AC, 
MUC2, and MUC6) in the gastric mucosa in similar areas, the 
semi-quantitative color intensity rating scale was used:  0 (none) - 
no positive reaction in the cells, 1 (weak) - up to 30% of the cells 
reacted positively, 2 ( moderate) - 31-60%, 3 (strong) - 60% or 
more stained cells [9].
Three  independent  investigators  examined  all  the 
sections  for  histopathological  study  and  a  blind  study  for 
immunohistochemical  evaluation  was  conducted  by  the  third 
one. The expression of mucins was evaluated by cytoplasmic 
staining. The results were expressed semiquantitatively for each 
histological group as the number of positively labeled sections, 
the predominantly labeled cell type, and the average score of 
the positively labeled cells. Positive Control Sections included 
control  tissues  taken  from  the  colon  and  stomach,  with  the 
previously  identified  MUC  gene  expression  patterns  included 
with each batch of sections for immunohistochemistry. Negative 
Control Sections involved eliminating the primary antibody as a 
negative control to test the specificity of the antibodies utilized 
for each section.
Statistical analysis: Results of the immunohistochemical 
alterations were compared with the clinical-pathologic features 
using the chi-square test for qualitative data, with a two- tailed 
p-value < 0.05 considered significant. 
All the investigations were performed in accordance with 
the  guidelines  of  the  Ukraine  National  Bioethics  Committee 
based  on  “Ethical  and  law  problems  of  clinical  trials  and 
scientific experiments with humans and animals” (Decision of 
the Presidium of The National Academy of Sciences of Ukraine 
from 07.11.2007 № 288) corresponding to international standards 
of animal welfare.
Results
The study of mucins in the gastric mucosa showed that a 
certain cell phenotype corresponds to a specific type of mucin. 
Therefore, the MUC5AC is found in the epithelium pits, while 
the MUC1 occurs in the mucous neck cells, the MUC6 occurs 
in the pyloric exocrinocytes, and the MUC2 occurs in goblet 
cells.  The  fact  that  the  MUC  5AC  is  selectively  synthesized 
by the epithelial cells of the pits and necks of the gland cells of 
normal gastric mucosa enables us to draw a conclusion that the 
epithelial cells of the necks of the gland cells may be identified 
as those producing the mucus. Due to the low specificity of the 
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expression in the cytoplasm of the mucous neck cells in only 2 
patients with CAG, and due to the absence of positive binding in 
the case of IM, we excluded it from further analysis. The MUC 
5AC marking was highly informative in all the investigated cases. 
Thus, the expression of the MUC 5AC has not been defined in the 
columnar epitheliocyte areas of complete IM despite its strong 
and moderate expression in the areas showing incomplete IM 
(Fig. 1a, b).
In the H. pylori group in association with HAG, the MUC 
5AC labeling was moderate and weak. After eradication of the H. 
pylori infection the expression of several of them was amplified. 
The MUC5AC expression prevailed in the columnar epithelial 
cells, although it occurred in 21% of the patients with incomplete 
IM in the cytoplasm and membranes of the goblet cells. In patients 
with a long history of CAG (over 3 years) and for over six years 
in the group subjected to dynamic monitoring, the loss of MUC 
5AC was observed in 34% of patients in the areas of incomplete 
IM and mild and severe dysplasia (Fig.2).
Decreased number of mucin positive cells was visible in 
the areas of incomplete IM adjacent to the cancer and in the 
neoplastic cells. However, in 37% of patients the MUC 5AC 
expression remained in the IM areas adjacent to the cancer IM 
and in the neoplastic cells, which may predominantly indicate a 
gastric type of adenocarcinoma (Fig.3). It should be noted that 
the loss of mucin-producing properties was observed mainly in 
patients  with  poorly  differentiated  adenocarcinoma,  although 
in 44% of patients with cancer signet-ring cells the carcinomas 
retained the MUC5AC labeling. 
The MUC 2 was moderately expressed in the cytoplasm and 
sometimes more strongly in the membranes of the goblet cells, 
and persisted during the observation in the cases of complete and 
incomplete IM (Fig.4). The goblet cells in the initial phases of 
secretion were wedge-shaped, with the apex directed towards the 
basal parts and the foundation towards the lumen of the stomach. 
In  the  areas  adjacent  to  the  adenocarcinoma  and  neoplastic 
modified cells, a weak expression of the MUC2 was observed. 
During  the  observation  we  found  no  positive  labeling  of  the 
MUC2 in the group of patients with gastric signet-ring cell cancer. 
The MUC6 expression was observed mainly in the pyloric 
exocrinocytes of the deep parts of the lamina propria; however, it 
was weak in the areas of incomplete IM and it was totally absent 
in the case of complete IM. Thus, the more profoundly the IM 
was spread, the weaker was the MUC6 expression, indicating a 
progressive displacement of the pyloric glands with the neogenic 
intestinal  epithelium  and  severe  IM  (stage  3  of  the  chronic 
atrophic metaplastic gastritis). While studying the biopsies from 
the fundus we noted the positive labeling of the exocrinocytes of 
the oxyntic glands (Fig.5) that confirms their restructuring and 
the development of pyloric metaplasia (pylorization).
Fig. 1 a 
CAG with complete and incomplete IM. 
The strong expression of the MUC5AC 
in the areas of incomplete IM (arrow) 
and the absence of mucin expression in 
the areas of complete IM (arrowhead). 
Immunohistochemical staining  x 100.
Fig 1 b
CAG with complete IM. The absence of 
MUC5 expression in the epitheliocytes 
with complete IM (arrow) and 
moderate expression in the 
superficial epitheliocytes (arrowhead) 
adjacent to the metaplastic area. 
Immunohistochemical staining x 200.
Fig. 2. 
The absence of the MUC 5AC expression in the foveolar epithelium (a) and surface 
epithelial cells (b) of the incomplete IM areas, and dysplasia in patients with CAG 
with incomplete IM (arrow). Immunohistochemical staining; a) magnification x 
400, b) magnification x 200.
Fig. 3.
 The moderate expression 
of the MUC5AC in the 
tumor cells with poorly 
differentiated stomach 
adenocarcinoma.  
Immunohistochemical 
staining x 400.
Fig. 4. 
The moderate expression 
of the MUC2 in the 
goblet cells of stomach 
glands. Chronic antral 
atrophic gastritis with 
areas of complete 
and incomplete IM. 
Immunohistochemical 
staining x 200.
Fig. 5.
The moderate expression 
of the MUC6 in the 
pyloric exocrinocytes 
and focal expression 
in the oxyntic glands. 
Chronic atrophic 
fundic gastritis with 
incomplete IM. 
Immunohistochemical 
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Therefore,  the  findings  of  the  immunohistochemical 
analysis of the profiles of the mucins indicate the presence of 
some mucin specificity in the different IM types (Tables 1-2). 
As can be seen from Table 2, when the IM was complete, 
maximum expression of the MUC 2 was visible in the goblet 
cells,  thus  the  MUC5AC,  MUC1,  and  MUC6  marking  were 
absent in the columnar epitheliocytes with a brush border. When 
the IM was incomplete and MUC2 marking of the goblet cells 
was positive, in 25% of patients with CAG with incomplete IM, 
the gastric mucin(MUC5AC) was observed as well; however, for 
the columnar epitheliocytes, it was characteristic that the gastric 
mucin was found in 100% of the patients observed, and as for the 
MUC2, it was observed in small amounts (15% of patients).
Discussion and Conclusion
The IM has now been recognized to be either a complete 
or an incomplete type of IM, or a small- (Type I and Type II) 
or large- (Type III) intestinal-type IM [10,11]. Although these 
classifications have generally been accepted, they overemphasize 
the characteristics common to the cells in the small intestine, 
while neglecting the existing gastric phenotype. However, the 
results of our investigations coincide with other researches [12, 
13] that suggested segregating the IM into two categories, i.e., a 
mixed gastric and intestinal (GI) type, and a solely intestinal (I) 
type, based on the residual gastric phenotype cells.
Thus, the separation of the gastrointestinal phenotype of 
IM, unlike the prior classification [10,11] which offered only 
intestinal  types  (mainly  intestinal  and  colonic)  enables  us  to 
consider the gastric and intestinal phenotypes. It helps us deepen 
our knowledge regarding the histogenesis of gastric cancer, as 
well as confirms the heterogeneity of IM.
1.  The  mucin  profile  can  be  used  for  the  differential 
diagnosing of various types of metaplastic changes in the gastric 
epithelium and the histological variants of gastric cancer.
2.  The  MUC5AC  expression  of  gastric  mucins  in  the 
columnar  epithelial  cells  and  goblet  exocrinocytes  marks  the 
formation of the gastrointestinal phenotype, incomplete intestinal 
metaplasia, along with the simultaneous production of MUC2 by 
goblet cells.
3. Most often the intestinal phenotype is characterized by 
the  absence  of  MUC5AC  in  the  columnar  epitheliocytes  and 
goblet exocrinocytes despite the MUC2 production by the goblet 
exocrinocytes.
4. MUC6 may serve as a marker for pyloric metaplasia, as 
its appearance in the cells of the glands shows pylorization and 
distribution of atrophic changes in the specialized glands of the 
stomach fundus.
5. The decrease with the further stop in the production of the 
protective MUC5AC by the columnar epithelial cells and goblet 
exocrinocytes that were in the areas of severe dysplasia and IM 
adjacent to the neoplastic altered cells may serve as additional 
criteria of the early malignancy of the gastric mucosa.
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Table 1. 
Chronic atrophic gastritis with complete intestinal metaplasia 
Mucins
Specificity
SFE MNC OE PC PE GS СCBB
MUC1 - + - - - - -
MUC2 +/- - - - - +++ -
MUC5AC - - ++ - - - -
MUC6 - - - - +++ - -
Note: SFE - superficial and foveolar epithelium, MNC - mucous neck cells, OE – 
oxyntic exocrinocytes, PC - parietal cells, PE – pyloric exocrinocytes, GS - goblet 
cells, CCBB - columnar epithelial cells with brush border. MUC - mucin, - no 
expression, + / - weak or absent, + weak expression, + + moderate, + + + strong 
expression.
Table 2. 
Chronic atrophic gastritis with incomplete intestinal metaplasia
Mucins
Specificity 
SFE MNC OE PC PE GS СCBB
MUC1 + + - - - +++ -
MUC2 - - - - - +++ +/-
MUC5AC +++ ++ ++ - - +/- +++
MUC6 - + + - +++ - -
Note: see Table 1.